Harrow Health, Inc.
USD32.86
-1.25 (-3.66%)
CEO
Mark L. Baum
IPO Date
2007-09-28
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$33.96
Prev. Close
$34.11
Day Low
$32.73
Day High
$34.65
52W Low
$27.76
52W High
$54.85
Market Cap
$1.22B
Volume
0.57M
| 1,000 |
| $31.00 |
| 18 May 2026 | Shojaei Amir | CHIEF SCIENTIFIC OFFICER | A-Award | Acquired | 10,000 | $0.00 |
| 15 May 2026 | BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | P-Purchase | Acquired | 10,000 | $30.20 |
| 15 May 2026 | BOLL ANDREW R. | PRESIDENT AND CFO | P-Purchase | Acquired | 3,500 | $29.90 |
| 5 Mar 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 59,000 | $39.15 |
| 5 Mar 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 1,309 | $39.15 |
| 5 Mar 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 134,000 | $39.67 |
| 5 Mar 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 4,263 | $39.67 |
| 3 Mar 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 5,000 | $54.18 |